CONMED Banking on Innovation to Stem Share Losses

CONMED reported 2Q25 orthopedic sales of $140.7 million, up 0.9% compared to the second quarter of 2024. For the first half of 2025, the company generated $279 million in orthopedic sales, up 1.7% compared to the prior year.

This year, CONMED is focused on three objectives to get its orthopedics business back on track: stabilizing and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0